26S proteasome 19S regulatory particle (19S RP)

The 26S proteasome 19S regulatory particle is a sophisticated multi-subunit complex that serves as the gatekeeper for the ubiquitin-proteasome system (UPS) (Finley, 2009, Annu Rev Biochem). It is responsible for the recognition, deubiquitination, unfolding, and translocation of polyubiquitinated protein substrates into the 20S proteolytic core for degradation (Bard et al., 2018, Annu Rev Biochem). Structurally, the 19S particle consists of a base containing six AAA+ ATPases that provide mechanical force for protein unfolding and a lid that facilitates substrate processing via deubiquitinating enzymes like Rpn11 (Li et al., 2016, Nature). This regulatory particle plays a critical role in maintaining cellular proteostasis, regulating the cell cycle, and managing stress responses (PubMed, NIH). In many cancers, particularly multiple myeloma, the 19S particle is often overexpressed or hyperactive to compensate for high rates of protein synthesis and misfolding (D'Arcy et al., 2011, Nature Medicine). Therapeutic strategies targeting the 19S particle, such as inhibitors of the Rpn11 deubiquitinase or the associated USP14 enzyme, are being developed to overcome resistance to conventional 20S proteasome inhibitors (Wang et al., 2018, Cell Chemical Biology). By blocking these specific regulatory functions, these drugs induce an accumulation of toxic ubiquitinated proteins, leading to proteotoxic stress and eventual cell death in malignant cells (PubMed). Understanding the 19S regulatory particle's dynamics is essential for developing next-generation proteasome-targeted therapies with improved selectivity and reduced side effects.

Other names

PA70019S capRegulatory particle26S proteasome regulatory subunit19S regulatory complex

Inhibition of deubiquitinating enzymes (Rpn11, USP14, UCHL5), interference with substrate recognition (Rpn13), or inhibition of the 26S holoenzyme complex activity.